U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06860841) titled 'Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM' on Feb. 21.
Brief Summary: This study evaluates the efficacy of D-Chiro-Inositol (DCI) as an add-on therapy to metformin in improving insulin resistance, measured by the HOMA index, in people with overweight or obesity and type 2 diabetes mellitus (T2DM). Secondary outcomes include glycemic variability, indirect calorimetry, respiratory quotient, and other metabolic parameters.
Study Start Date: Jan. 10
Study Type: INTERVENTIONAL
Condition:
Obese Diabetics
Overweight (BMI > 25)
Obese Patients
Insuli...